Article (Scientific journals)
Practice guidelines on the use of erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia
Dirix, L.; Awada, A.; Bron, D. et al.
2010In Belgian Journal of Medical Oncology, 4, p. 57-64
Peer Reviewed verified by ORBi
 

Files


Full Text
266.pdf
Publisher postprint (132.44 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
chemotherapy-induces anemia; erythropoiesis-stimulating agents
Abstract :
[en] On July 1st 2009, a panel of experts met with the goal to provide a joint medical opinion on the use of erythropoiesis-stimulating agents (ESAs) in chemotherapy-induced anemia (CIA), as well as a joint proposal for revised reimbursement criteria in Belgium. The goal is to provide a clear and workable guidance on the use of ESAs in their registrered indication : chemotherapy induced anemia in cancer patients. An overview of participating experts can be found in Table 1.
Disciplines :
Hematology
Author, co-author :
Dirix, L.
Awada, A.
Bron, D.
Canon, J.-L.
De Grève, J.
Humblet, Y.
Peeters, M.
Van Belle, S.
Vansteenkiste, J.
Beguin, Yves  ;  Université de Liège - ULiège > GIGA-R : Hématologie
Vermorken, J.
Language :
English
Title :
Practice guidelines on the use of erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia
Publication date :
2010
Journal title :
Belgian Journal of Medical Oncology
ISSN :
1784-7141
Publisher :
Ariez Medical Publishing, Amsterdam, Netherlands
Volume :
4
Pages :
57-64
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 25 December 2010

Statistics


Number of views
109 (2 by ULiège)
Number of downloads
310 (2 by ULiège)

Bibliography


Similar publications



Contact ORBi